The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Woth registering at Reserach Tree. Cenkos have issued a note on the back of the half year results and modelled to end FY 2023. Also confirms the payment profile from THX assuming successfully closed
I rarely comment on the musings here but I really am genuinely embarrassed for you Porks
She's gonna blow captain
Unusual amount of action over on PYC also RB
Well said Adam.
Now is not the time to take any such action. Rather to augment the skillset available to the BoD to help them deliver
Certainly looks like everyone has taken their positions RB. One decent buy might well reveal the current illiquid nature and where off to the races
Agree RB. It's easy to forget where we were under the old watch compared to now
I think that’s the problem TDK. I don’t think the BOD are in the tent and don’t get the oversight a well executed LoI would include
Cenkos have updated the market post yesterdays RNS with a broker note. They maintain their buy recommendation noting that they anticipate several value inflextion points in the near term
I don’t think a lack of commercial acumen on the board makes them charlatans personally. They have strategy and vision to correct the damage done historically and to build the asset base. I do however have a concern about the degree of oversight baked into some of the relationships that are in place.
The issue here is that we are not aware to what extent Val are in the room.
You get what you inspect not what you expect. The comms for both 201 and 301 suggest the arrangements are more on trust than commercial with break points and penalties. The arrangements with Cenkos and PYC also smack of this leaving Val to report on what they are told, not what they have seen. Not therefore surprising there are jitters . AGM gives BoD opportunity to address this
Just as we suggested RB
Another run at 30 is coming today :-)
Enjoy RB
Looks like a cracking day to get the old Triton out.
Blue all the way !
Hi all,
New research note available on research tree
I was talking with a guy on the IPO circuit yesterday.
He confirmed what was stated in the RNS. Sanctions and uncertainty have had a significant effect on investors and funds available for commitment. As we know TX are securing funds for a portfolio of oncology candidates not just 201 so not surprising that an environment unforseen when the original timeframe was set has an impact.
For me the wording was clear. The trial is ready to go and with funds invested and the remainder identified and in train. This will be back to 30p imo and then build.
Indeed PM
I also answered PMQs for the civil service in past life and know fine well how to read what is being said without a direct statement! All should read the RNS twice and objectively
As I said yesterday the CEO and Chairman of TX have excellent pedigrees.
As someone who lost a successful business overnight in 2008 in the banking crisis I know fine well how fund raising sentiment can change in challenging economic circumstances.
If you read the RNS the trial is ready to go and confidence is high that this will conclude successfully and sooner than June.
Remains a strong buy for me imo
Just idly trawling and can across Patrick Frankham who had been part of the team setting up TheoremRx. Interestingly he was a Board member of Pivot who help an interest in a portfolio of candidates targeted at unmet need in womens health. Sound familiar?
He has some intesrsting contacts and is, of course, connected to Suzy
It seems re-writing history is in vogue rihht now TDK